Traditional Chinese herbal medicine in treating amenorrhea caused by antipsychotic drugs
Meta-analysis and systematic review
Bibliographic Data
| ID | 14737449 |
|---|---|
| Authors | Liangshuai Liu (0000-0001-6111-6478), Heping Li (0000-0001-8284-0449), Guosheng Tan (0000-0001-5230-0441), Zhenjiang Ma (0000-0001-8270-3444) |
| Year | 2022 |
| Volume | 289 |
| Pages | 115044 |
| Publication date | 2022-05-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2022.115044 |
| Language | EN |
| Citations received | 3 |
| References cited | 41 |
Mechanism exploration of Jiajian Yiguan decoction in treating Sjögren's syndrome
Traditional Chinese medicine for antipsychotic-induced hyperprolactinemia
Integrated transcriptomic and proteomic analysis reveals that the anti-endometriosis effects of Pingchong Jiangni recipe may involve pathways and genes/proteins related to inflammation, autophagy, mitochondrial function, and angiogenesis in ectopic endometrial stromal cells
Assessing heterogeneity in meta-analysis
Basics of meta‐analysis
Paeoniflorin and liquiritin, two major constituents in Chinese herbal formulas used to treat hyperprolactinemia-associated disorders, inhibits prolactin secretion in prolactinoma cells by different mechanisms
Literature data based systems pharmacology uncovers the essence of “body fire” in traditional Chinese medicine
The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer
The ancient Chinese formula Longdan Xiegan Tang improves antipsychotic-induced hyperprolactinemia by repairing the hypothalamic and pituitary TGF-β1 signaling in rats
A review of traditional and current methods used to potentially reduce toxicity of Aconitum roots in Traditional Chinese Medicine
| Unique citing works | 3 |
|---|---|
| Citations per year | 3 |
| Citation span | 2025 - 2026 (2) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 3 |